CULLINAN THERAPEUTICS, INC.
One Main Street, Suite 1350
Cambridge, MA 02142
May 31, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tamika Sheppard
| Re: | Cullinan Therapeutics, Inc. |
Registration Statement on Form S-3 (File No. 333-279452)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cullinan Therapeutics, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on June 4, 2024, or as soon as possible thereafter. The Company hereby authorizes Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 as soon as the registration statement has been declared effective.
[Signature page follows]
| Very truly yours, | ||
| CULLINAN THERAPEUTICS, INC. | ||
| By: | /s/ Mary Kay Fenton | |
| Name: | Mary Kay Fenton | |
| Title: | Chief Financial Officer | |
[Signature Page to Acceleration Request]